Laurie A. Lee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Laurie A. Lee has a total of 109 co-authors. Here are the top co-authors by number of shared publications:
Kirsten M. Fiest
Department of Critical Care Medicine, Cumming School of Medicine, University of Calgary, Calgary, Canada
4 shared publications- Amanda Y. Leong
Department of Critical Care Medicine, Cumming School of Medicine, University of Calgary, Calgary, Canada
2 shared publications Corey Slumkoski
Department of Pediatric Critical Care Patient Partnerships, IWK Health, Halifax, NS, Canada
2 shared publications- Daniel J. Niven
Department of Critical Care Medicine, Cumming School of Medicine, University of Calgary, Calgary, Canada
2 shared publications Dori-Ann Martin
Alberta Children’s Hospital Research Institute, University of Calgary, Calgary, AB, Canada
2 shared publications- Jamie A. Seabrook
Human Environments Analysis Laboratory, Western University, London, ON N6A 3K7, Canada
2 shared publications
Latest Publications
- Open Access
- 18 August 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15, e89824
Exploration of Factors That Influence Clinical Nurses’ Active Engagement in Research and Evidence-Based Practice: Protocol for a Scoping Review
Background: Nurses rely on current and relevant evidence to provide safe, high-quality care to patients and families. To do this, nurses need support to participate in research and evidence-based practice (EBP) activities. Despite the well-documented benefits of nurses’ engagement in research and EBP, few actually do so in the clinical setting. This creates a knowledge-to-practice gap in which nursing evidence is not generated and existing evidence is often not applied in practice, jeopardizing the quality of care and patient outcomes. Objective: The aim of this scoping review is to identify and map the evidence on factors that influence clinical nurses’ engagement in research and/or EBP. Methods: This review will be conducted in accordance with the JBI methodology for scoping reviews and reported in accordance with the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews) checklist. Searches were conducted on April 28, 2025, in 5 health-related databases. Titles and abstracts, and then full-text articles, were screened by 2 independent researchers against the eligibility criteria for inclusion. The eligibility criteria include research studies (ie, qualitative, quantitative, and mixed methods) and reviews that describe factors that influence nurses working in a clinical setting or in an outpatient clinic attached to a tertiary hospital to engage in research and/or EBP activities. Studies must be published in English after 2010 and conducted in high-income countries. Data will be extracted into a data extraction table adapted from the JBI data extraction instrument by an independent researcher and checked by another. The data from the included studies will be presented in tabular form, accompanied by a narrative summary. Results: Database searches identified 11,051 records, of which 50.2% (n=5544) remained after duplicate records were removed. Screening began in May 2025, and full-text screening was completed in November 2025. Data extraction and synthesis began in November 2025. Results are planned to be submitted for publication in the summer of 2026. Conclusions: The findings from this scoping review will inform the development of targeted interventions and organizational strategies that enhance clinical nurses’ engagement in research and EBP. This will better position nurses to improve the quality of care provided to patients and families, thereby improving patient outcomes and advancing the nursing profession. Trial Registration: Open Science Framework 10.17605/OSF.IO/5VWE9; https://osf.io/5vwe9 International Registered Report Identifier (IRRID): DERR1-10.2196/89824
- 18 August 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15, e89824
Open AccessExploration of Factors That Influence Clinical Nurses’ Active Engagement in Research and Evidence-Based Practice: Protocol for a Scoping Review
Background: Nurses rely on current and relevant evidence to provide safe, high-quality care to patients and families. To do this, nurses need support to participate in research and evidence-based practice (EBP) activities. Despite the well-documented benefits of nurses’ engagement in research and EBP, few actually do so in the clinical setting. This creates a knowledge-to-practice gap in which nursing evidence is not generated and existing evidence is often not applied in practice, jeopardizing the quality of care and patient outcomes. Objective: The aim of this scoping review is to identify and map the evidence on factors that influence clinical nurses’ engagement in research and/or EBP. Methods: This review will be conducted in accordance with the JBI methodology for scoping reviews and reported in accordance with the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews) checklist. Searches were conducted on April 28, 2025, in 5 health-related databases. Titles and abstracts, and then full-text articles, were screened by 2 independent researchers against the eligibility criteria for inclusion. The eligibility criteria include research studies (ie, qualitative, quantitative, and mixed methods) and reviews that describe factors that influence nurses working in a clinical setting or in an outpatient clinic attached to a tertiary hospital to engage in research and/or EBP activities. Studies must be published in English after 2010 and conducted in high-income countries. Data will be extracted into a data extraction table adapted from the JBI data extraction instrument by an independent researcher and checked by another. The data from the included studies will be presented in tabular form, accompanied by a narrative summary. Results: Database searches identified 11,051 records, of which 50.2% (n=5544) remained after duplicate records were removed. Screening began in May 2025, and full-text screening was completed in November 2025. Data extraction and synthesis began in November 2025. Results are planned to be submitted for publication in the summer of 2026. Conclusions: The findings from this scoping review will inform the development of targeted interventions and organizational strategies that enhance clinical nurses’ engagement in research and EBP. This will better position nurses to improve the quality of care provided to patients and families, thereby improving patient outcomes and advancing the nursing profession. Trial Registration: Open Science Framework 10.17605/OSF.IO/5VWE9; https://osf.io/5vwe9 International Registered Report Identifier (IRRID): DERR1-10.2196/89824
- Open Access
- 17 December 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Exploration of factors that influence clinical nurses’ active engagement in research and evidence-based practice: Protocol for a Scoping Review (Preprint)
BACKGROUND Nurses rely on current and relevant evidence to provide safe, high-quality care to patients and families. To do this, nurses need support to participate in research and evidence-based practice (EBP) activities. Despite the well-documented benefits of nurses' engagement in research and EBP, few actually do so in the clinical setting. This creates a knowledge-to-practice gap in which nursing evidence is not generated and existing evidence is often not applied in practice, jeopardizing the quality of care and patient outcomes. OBJECTIVE The aim of this scoping review is to identify and map evidence on factors that influence clinical nurses’ engagement in research and/or EBP. METHODS This review will be conducted in accordance with the JBI methodology for scoping reviews and reported in accordance with the Preferred Reporting Items for Systematic Reviews (PRISMA-ScR) checklist. Searches were conducted on April 28, 2025 in five health-related databases. Titles and abstracts, and then full-text articles, were screened by two independent researchers against eligibility criteria for inclusion. Eligibility criteria include research studies (i.e. qualitative, quantitative, and mixed-methods) and reviews that describe factors that influence nurses working in a clinical setting or an outpatient clinic attached to a tertiary hospital to engage in research and/or EBP activities. Studies must be published in English after 2010 in developed countries. Data will be extracted into a data extraction table adapted from the JBI data extraction instrument by an independent researcher and checked by another. The data from the included studies will be presented in tabular form, accompanied by a narrative summary. RESULTS Database searches identified 11,051 records, of which 5,544 remained after duplicates were removed. Screening began in May 2025, and full-text screening was completed November 2025. Data extraction and synthesis began November 2025. Results are planned to be submitted for publication summer of 2026. CONCLUSIONS The findings from this scoping review will inform the development of targeted interventions and organizational strategies that enhance clinical nurses' engagement in research and EBP. This will better position nurses to improve the quality of care provided to patients and families, improving patient outcomes, and advancing the nursing profession. CLINICALTRIAL Open Science Framework (https://osf.io/5vwe9)
- 17 December 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessExploration of factors that influence clinical nurses’ active engagement in research and evidence-based practice: Protocol for a Scoping Review (Preprint)
BACKGROUND Nurses rely on current and relevant evidence to provide safe, high-quality care to patients and families. To do this, nurses need support to participate in research and evidence-based practice (EBP) activities. Despite the well-documented benefits of nurses' engagement in research and EBP, few actually do so in the clinical setting. This creates a knowledge-to-practice gap in which nursing evidence is not generated and existing evidence is often not applied in practice, jeopardizing the quality of care and patient outcomes. OBJECTIVE The aim of this scoping review is to identify and map evidence on factors that influence clinical nurses’ engagement in research and/or EBP. METHODS This review will be conducted in accordance with the JBI methodology for scoping reviews and reported in accordance with the Preferred Reporting Items for Systematic Reviews (PRISMA-ScR) checklist. Searches were conducted on April 28, 2025 in five health-related databases. Titles and abstracts, and then full-text articles, were screened by two independent researchers against eligibility criteria for inclusion. Eligibility criteria include research studies (i.e. qualitative, quantitative, and mixed-methods) and reviews that describe factors that influence nurses working in a clinical setting or an outpatient clinic attached to a tertiary hospital to engage in research and/or EBP activities. Studies must be published in English after 2010 in developed countries. Data will be extracted into a data extraction table adapted from the JBI data extraction instrument by an independent researcher and checked by another. The data from the included studies will be presented in tabular form, accompanied by a narrative summary. RESULTS Database searches identified 11,051 records, of which 5,544 remained after duplicates were removed. Screening began in May 2025, and full-text screening was completed November 2025. Data extraction and synthesis began November 2025. Results are planned to be submitted for publication summer of 2026. CONCLUSIONS The findings from this scoping review will inform the development of targeted interventions and organizational strategies that enhance clinical nurses' engagement in research and EBP. This will better position nurses to improve the quality of care provided to patients and families, improving patient outcomes, and advancing the nursing profession. CLINICALTRIAL Open Science Framework (https://osf.io/5vwe9)
- 21 October 2025
- Published by Springer Nature in Intensive Care Medicine
- Vol. 51 (11) , 2093-2103
Prevalence and incidence of ICU delirium and pain: a systematic review and meta-analysis
Purpose We performed a secondary analysis of a prior systematic review and meta-analysis to examine the prevalence and incidence of ICU delirium and pain. Methods The original search examined MEDLINE, EMBASE, CINAHL, and the Cochrane Central Register of Controlled trials from inception to May 15, 2023 (PROSPERO ID: CRD42022367715). Articles eligible for the current study derived from those previously reviewed at full text review. Included in the current study were randomised or observational studies among critically ill adults, that reported delirium or pain incidence or prevalence. Proportion data was transformed using the Freeman-Tukey double arcsine method prior to pooling using a random effects meta-analysis model. Joanna Briggs’ Institute prevalence checklist was used for risk of bias. Results From 517 full-text articles, 213 original studies, 226 publications (183,285 patients) were included. The pooled delirium prevalence (173 studies) was 35.7% (95%CI 32.4–39.0%). The most common delirium subtype was hypoactive (16.5%, 95%CI 12.1–21.4%). The pooled delirium incidence (41 studies) was 28.8% (95%CI 23.2–34.8%). The pooled pain prevalence (11 studies) was 43.5% (95%CI 28.6–58.9%). Delirium prevalence but not incidence decreased since 2013 (before: 39.9%, 95%CI 34.7–45.3% vs. after: 32.3%, 95%CI 28.2–36.5%, p = 0.02). Pain prevalence decreased significantly since publication of pain, agitation and delirium guidelines in 2013 (before: 64.6%, 95%CI 41.6–84.6% vs. after: 35.8%, 95%CI 20.5–52.6%, p = 0.046). Conclusions Delirium and pain prevalence among adults admitted to ICUs have decreased since publication of pain, agitation and delirium guidelines. However, both remain common, occurring in up to one-half of patients.
- 21 October 2025
- Published by Springer Nature in Intensive Care Medicine
- Vol. 51 (11) , 2093-2103
Prevalence and incidence of ICU delirium and pain: a systematic review and meta-analysis
Purpose We performed a secondary analysis of a prior systematic review and meta-analysis to examine the prevalence and incidence of ICU delirium and pain. Methods The original search examined MEDLINE, EMBASE, CINAHL, and the Cochrane Central Register of Controlled trials from inception to May 15, 2023 (PROSPERO ID: CRD42022367715). Articles eligible for the current study derived from those previously reviewed at full text review. Included in the current study were randomised or observational studies among critically ill adults, that reported delirium or pain incidence or prevalence. Proportion data was transformed using the Freeman-Tukey double arcsine method prior to pooling using a random effects meta-analysis model. Joanna Briggs’ Institute prevalence checklist was used for risk of bias. Results From 517 full-text articles, 213 original studies, 226 publications (183,285 patients) were included. The pooled delirium prevalence (173 studies) was 35.7% (95%CI 32.4–39.0%). The most common delirium subtype was hypoactive (16.5%, 95%CI 12.1–21.4%). The pooled delirium incidence (41 studies) was 28.8% (95%CI 23.2–34.8%). The pooled pain prevalence (11 studies) was 43.5% (95%CI 28.6–58.9%). Delirium prevalence but not incidence decreased since 2013 (before: 39.9%, 95%CI 34.7–45.3% vs. after: 32.3%, 95%CI 28.2–36.5%, p = 0.02). Pain prevalence decreased significantly since publication of pain, agitation and delirium guidelines in 2013 (before: 64.6%, 95%CI 41.6–84.6% vs. after: 35.8%, 95%CI 20.5–52.6%, p = 0.046). Conclusions Delirium and pain prevalence among adults admitted to ICUs have decreased since publication of pain, agitation and delirium guidelines. However, both remain common, occurring in up to one-half of patients.
- Open Access
- 1 October 2025
- Published by Elsevier in Australian Critical Care
- Vol. 38 (6) , 101440
Identifying barriers and facilitators to therapeutic cuddling in the paediatric intensive care unit: A survey guided by the theoretical domains framework
- 1 October 2025
- Published by Elsevier in Australian Critical Care
- Vol. 38 (6) , 101440
Open AccessIdentifying barriers and facilitators to therapeutic cuddling in the paediatric intensive care unit: A survey guided by the theoretical domains framework
- 4 April 2025
- Published by Wolters Kluwer Health in Nursing Research
- Vol. 74 (5) , 391-398
Considerations in Launching an International Multisite Clinical Trial
Background: Adequately powered randomized controlled clinical trials (RCTs) provide the highest level of evidence to support nursing interventions that are thought to improve clinical outcomes. To ensure adequate power, recruitment at multiple study sites is often required. Complexity is exponentiated when RCTs are conducted in multiple settings, especially on an international level. Regardless of logistical challenges, funders typically expect subjects to be enrolled within the first year of funding. Objective: To describe essential elements that must be considered when launching a multisite RCT. Methods: Step-by-step review of essential multisite RCT start-up activities using PROSpect, a nurse-led 50+ site international pediatric critical care RCT, as an exemplar. Essential pre- and postaward activities and organizational structure are discussed. The PROSpect launch timeline, with comparisons between United States and international study site initiation, is presented. Results: In the first 2 years of PROSpect funding (June 15, 2018–June 14, 2020), 54 sites in 13 countries spanning five continents initiated study launch activities and subsequently went on to begin subject screening. Of these, 15 sites (28%) began screening within the first funding year and 29 (54%) within the second year. PROSpect enrolled its first subject prior to the end of the first year of funding. Sites completed launch activities within a median of 295 days of receiving an instructional e-mail delineating study launch steps (IQR: 202, 379; range = 151–1,046). International sites (n = 19) required more time to launch than U.S. sites (n = 35; 448 [360, 785] vs. 219 [201, 299] days; p < .001). Discussion: Nurses must provide care that is supported by the best available evidence. Multisite RCTs are complex but provide high-quality evidence and can be managed with prospective systematic organization. In PROSpect, international sites took approximately twice as long to activate as U.S. sites. When developing a study start-up timeline, it is important to adjust milestones to accommodate the complexities of launching international sites and maintain momentum throughout the process, as start-up delays can increase the risk of trial failure. This paper contributes to recent efforts to demystify and streamline the multisite RCT start-up process for nurse investigators transitioning from conducting single-site to multisite trials.
- 4 April 2025
- Published by Wolters Kluwer Health in Nursing Research
- Vol. 74 (5) , 391-398
Considerations in Launching an International Multisite Clinical Trial
Background: Adequately powered randomized controlled clinical trials (RCTs) provide the highest level of evidence to support nursing interventions that are thought to improve clinical outcomes. To ensure adequate power, recruitment at multiple study sites is often required. Complexity is exponentiated when RCTs are conducted in multiple settings, especially on an international level. Regardless of logistical challenges, funders typically expect subjects to be enrolled within the first year of funding. Objective: To describe essential elements that must be considered when launching a multisite RCT. Methods: Step-by-step review of essential multisite RCT start-up activities using PROSpect, a nurse-led 50+ site international pediatric critical care RCT, as an exemplar. Essential pre- and postaward activities and organizational structure are discussed. The PROSpect launch timeline, with comparisons between United States and international study site initiation, is presented. Results: In the first 2 years of PROSpect funding (June 15, 2018–June 14, 2020), 54 sites in 13 countries spanning five continents initiated study launch activities and subsequently went on to begin subject screening. Of these, 15 sites (28%) began screening within the first funding year and 29 (54%) within the second year. PROSpect enrolled its first subject prior to the end of the first year of funding. Sites completed launch activities within a median of 295 days of receiving an instructional e-mail delineating study launch steps (IQR: 202, 379; range = 151–1,046). International sites (n = 19) required more time to launch than U.S. sites (n = 35; 448 [360, 785] vs. 219 [201, 299] days; p < .001). Discussion: Nurses must provide care that is supported by the best available evidence. Multisite RCTs are complex but provide high-quality evidence and can be managed with prospective systematic organization. In PROSpect, international sites took approximately twice as long to activate as U.S. sites. When developing a study start-up timeline, it is important to adjust milestones to accommodate the complexities of launching international sites and maintain momentum throughout the process, as start-up delays can increase the risk of trial failure. This paper contributes to recent efforts to demystify and streamline the multisite RCT start-up process for nurse investigators transitioning from conducting single-site to multisite trials.
- Open Access
- 3 April 2025
- Published by Elsevier in Journal of Pediatric Health Care
- Vol. 39 (5) , 825-835
Defining Priorities for Canadian PICU Family Presence Policies Under Changing Contexts: A Qualitative Focus Group Study
- 3 April 2025
- Published by Elsevier in Journal of Pediatric Health Care
- Vol. 39 (5) , 825-835
Open AccessDefining Priorities for Canadian PICU Family Presence Policies Under Changing Contexts: A Qualitative Focus Group Study
- 14 February 2025
- Published by Wolters Kluwer Health in JBI Evidence Synthesis
- Vol. 23 (6) , 1150-1190
Outcomes associated with family presence at the bedside of critically ill children in the pediatric intensive care unit: a scoping review
Objective: The objective of this review is to identify the outcomes of family presence in pediatric intensive care units (PICUs) that have been studied and reported in the literature. Introduction: PICU admission can be traumatic for children and their families. While family presence at the patient bedside is recommended to support family participation and engagement in care and is supported in recent family-centered care guidelines, it is not consistently optimized. To guide family presence research, a scoping review is needed to identify outcomes associated with family presence. Inclusion criteria: This review included quantitative, qualitative, and mixed methods studies published from 1960 to 2022 that reported outcomes of family presence at the bedside in the PICU for patients, their family members, and PICU health care professionals (HCPs). Methods: Following JBI methodology for scoping reviews, we searched MEDLINE (Ovid), PsycINFO (EBSCOhost), CINAHL (EBSCOhost), Embase, as well as 16 sources of gray literature for studies that addressed outcomes of family presence at the bedside in the PICU as they relate to the key participants. Two independent reviewers screened titles and abstracts, followed by full texts of selected records according to the inclusion criteria. A priori, we identified categories of outcomes (biologic, psychologic, social, caring behavior) and key groups (HCPs, patients, families) to which the outcomes may apply. Data were extracted by 2 independent reviewers using a data extraction tool developed by the study team. Data were presented in tabular format to address findings related to the review objectives. Results: We identified 12,411 records through database searches, backward reference chaining, and gray literature searching. We removed 3012 duplicates, excluded 9244 records at the title and abstract review, and excluded 92 reports after full-text review. We extracted data from 62 studies of which 12 were mixed methods, 25 were quantitative, and 25 were qualitative, spanning from 1982 to 2022. Of 46 unique outcomes, 40 studies addressed 28 outcomes for family members (13 psychologic, 8 social, 5 biologic, 2 caring behaviors; stress was the most common, reported in 11 studies). Twenty studies addressed 16 outcomes for patients (7 psychologic, 6 biologic, 2 caring behaviors, 1 other; out-of-bed mobilization was the most common, reported in 4 studies). Ten studies addressed 8 outcomes for HCPs (3 psychologic, 3 caring behaviors, 1 social, 1 other; procedural performance was the most common, reported in 3 studies). Overall, the most common biologic outcome reported was sleep (7 studies; 6 for family members and 1 for patients); the most common psychologic outcome reported was stress (13 studies; 11 for family members and 2 for HCPs); the most common social outcomes reported were role changes (4 studies; all 4 for family members) and financial challenges (4 studies for family members); and the most common caring behavior outcome was out-of-bed mobility (4 studies for patients). Conclusions: A relatively large, heterogeneous body of literature addresses biologic, psychologic, social, and caring behavior outcomes associated with family presence at the bedside of children in the PICU, for family members, patients, and HCPs. The review highlights the heterogeneity of available data and identifies a need for a concerted analysis. Important gaps remain, including social and longer-term mental health outcomes for patients, outcomes for siblings, and infection transmission for all key groups.
- 14 February 2025
- Published by Wolters Kluwer Health in JBI Evidence Synthesis
- Vol. 23 (6) , 1150-1190
Outcomes associated with family presence at the bedside of critically ill children in the pediatric intensive care unit: a scoping review
Objective: The objective of this review is to identify the outcomes of family presence in pediatric intensive care units (PICUs) that have been studied and reported in the literature. Introduction: PICU admission can be traumatic for children and their families. While family presence at the patient bedside is recommended to support family participation and engagement in care and is supported in recent family-centered care guidelines, it is not consistently optimized. To guide family presence research, a scoping review is needed to identify outcomes associated with family presence. Inclusion criteria: This review included quantitative, qualitative, and mixed methods studies published from 1960 to 2022 that reported outcomes of family presence at the bedside in the PICU for patients, their family members, and PICU health care professionals (HCPs). Methods: Following JBI methodology for scoping reviews, we searched MEDLINE (Ovid), PsycINFO (EBSCOhost), CINAHL (EBSCOhost), Embase, as well as 16 sources of gray literature for studies that addressed outcomes of family presence at the bedside in the PICU as they relate to the key participants. Two independent reviewers screened titles and abstracts, followed by full texts of selected records according to the inclusion criteria. A priori, we identified categories of outcomes (biologic, psychologic, social, caring behavior) and key groups (HCPs, patients, families) to which the outcomes may apply. Data were extracted by 2 independent reviewers using a data extraction tool developed by the study team. Data were presented in tabular format to address findings related to the review objectives. Results: We identified 12,411 records through database searches, backward reference chaining, and gray literature searching. We removed 3012 duplicates, excluded 9244 records at the title and abstract review, and excluded 92 reports after full-text review. We extracted data from 62 studies of which 12 were mixed methods, 25 were quantitative, and 25 were qualitative, spanning from 1982 to 2022. Of 46 unique outcomes, 40 studies addressed 28 outcomes for family members (13 psychologic, 8 social, 5 biologic, 2 caring behaviors; stress was the most common, reported in 11 studies). Twenty studies addressed 16 outcomes for patients (7 psychologic, 6 biologic, 2 caring behaviors, 1 other; out-of-bed mobilization was the most common, reported in 4 studies). Ten studies addressed 8 outcomes for HCPs (3 psychologic, 3 caring behaviors, 1 social, 1 other; procedural performance was the most common, reported in 3 studies). Overall, the most common biologic outcome reported was sleep (7 studies; 6 for family members and 1 for patients); the most common psychologic outcome reported was stress (13 studies; 11 for family members and 2 for HCPs); the most common social outcomes reported were role changes (4 studies; all 4 for family members) and financial challenges (4 studies for family members); and the most common caring behavior outcome was out-of-bed mobility (4 studies for patients). Conclusions: A relatively large, heterogeneous body of literature addresses biologic, psychologic, social, and caring behavior outcomes associated with family presence at the bedside of children in the PICU, for family members, patients, and HCPs. The review highlights the heterogeneity of available data and identifies a need for a concerted analysis. Important gaps remain, including social and longer-term mental health outcomes for patients, outcomes for siblings, and infection transmission for all key groups.
- 11 February 2025
- Published by Wolters Kluwer Health in Pediatric Critical Care Medicine
- Vol. 26 (4) , e531-e543
Systematic Review and Meta-Analysis of Prevalence and Population-Level Factors Contributing to Posttraumatic Stress Disorder in Pediatric Intensive Care Survivors
OBJECTIVES: In survivors of illnesses or surgeries requiring PICU admission, there is a risk of posttraumatic stress disorder (PTSD). We aimed to estimate PTSD prevalence and potential contributing factors in survivors of PICU admission. DATA SOURCES: We performed a PROSPERO registered systematic review (CRD42022348997; Registered August 2022) using MEDLINE, Embase, CINAHL, and Cochrane Central Register of Controlled Trials (CENTRAL) databases, 2000 to 2022, with no language restrictions. STUDY SELECTION: Observational or interventional studies evaluating the incidence or prevalence of PTSD in patients’ after PICU admission and/or contributing factors to PTSD. We used studies describing patients younger than 18 years old. Since there were a large number of citations, we used an integrated crowdsourcing and machine-learning model for citation screening. Each citation was reviewed independently and in duplicate by two reviewers at each stage of screening and abstraction. DATA EXTRACTION: Data items included study and participant demographics, details of case definition (PTSD screening), and risk factors. DATA SYNTHESIS: We followed the Preferred Reporting items for Systematic Reviews and Meta-analysis guidelines. Random-effects models were used to analyze PTSD prevalence and subgroup differences. In 24 citations meeting final review criteria, 19 had data for meta-analysis. There were 1898 PICU survivors with a median (interquartile range) cohort size of 59 (49–76). PTSD prevalence in the studies ranged from 3% to 37%; PTSD occurred in 529 of 1898 survivors (I 2 = 72%). Factors influencing PTSD variability included timing of assessment (p < 0.01) with the highest prevalence (29%) at 6 months and the type of assessment instrument (n = 10; range, 4–27%; p = 0.04). There was lower prevalence of PTSD (8%) in postoperative cardiac patients (p < 0.01). Last, we failed to find an association between PICU length of stay and PTSD prevalence (p = 0.62; I 2 = 80%). CONCLUSIONS: PICU follow-up studies from 2000 to 2022 indicate that one-in-three of admissions surviving to 6 months have PTSD. However, there are population, study design factors and heterogeneity in PTSD assessment that indicate more standardization in this research is needed.
- 11 February 2025
- Published by Wolters Kluwer Health in Pediatric Critical Care Medicine
- Vol. 26 (4) , e531-e543
Systematic Review and Meta-Analysis of Prevalence and Population-Level Factors Contributing to Posttraumatic Stress Disorder in Pediatric Intensive Care Survivors
OBJECTIVES: In survivors of illnesses or surgeries requiring PICU admission, there is a risk of posttraumatic stress disorder (PTSD). We aimed to estimate PTSD prevalence and potential contributing factors in survivors of PICU admission. DATA SOURCES: We performed a PROSPERO registered systematic review (CRD42022348997; Registered August 2022) using MEDLINE, Embase, CINAHL, and Cochrane Central Register of Controlled Trials (CENTRAL) databases, 2000 to 2022, with no language restrictions. STUDY SELECTION: Observational or interventional studies evaluating the incidence or prevalence of PTSD in patients’ after PICU admission and/or contributing factors to PTSD. We used studies describing patients younger than 18 years old. Since there were a large number of citations, we used an integrated crowdsourcing and machine-learning model for citation screening. Each citation was reviewed independently and in duplicate by two reviewers at each stage of screening and abstraction. DATA EXTRACTION: Data items included study and participant demographics, details of case definition (PTSD screening), and risk factors. DATA SYNTHESIS: We followed the Preferred Reporting items for Systematic Reviews and Meta-analysis guidelines. Random-effects models were used to analyze PTSD prevalence and subgroup differences. In 24 citations meeting final review criteria, 19 had data for meta-analysis. There were 1898 PICU survivors with a median (interquartile range) cohort size of 59 (49–76). PTSD prevalence in the studies ranged from 3% to 37%; PTSD occurred in 529 of 1898 survivors (I 2 = 72%). Factors influencing PTSD variability included timing of assessment (p < 0.01) with the highest prevalence (29%) at 6 months and the type of assessment instrument (n = 10; range, 4–27%; p = 0.04). There was lower prevalence of PTSD (8%) in postoperative cardiac patients (p < 0.01). Last, we failed to find an association between PICU length of stay and PTSD prevalence (p = 0.62; I 2 = 80%). CONCLUSIONS: PICU follow-up studies from 2000 to 2022 indicate that one-in-three of admissions surviving to 6 months have PTSD. However, there are population, study design factors and heterogeneity in PTSD assessment that indicate more standardization in this research is needed.
- 22 January 2025
- Published by Springer Nature in Intensive Care Medicine
- Vol. 51 (2) , 342-352
The association between pain, analgesia, and delirium among critically ill adults: a systematic review and meta-analysis
Purpose We performed a systematic review with meta-analysis examining the relationship between pain or pain medications and delirium occurence, duration, and severity. Methods We searched MEDLINE, EMBASE, CINAHL and the Cochrane Central Register of Controlled Trials from inception to May 15, 2023. We included randomised or observational studies among critically ill adults, that reported data on pain or exposure to analgesics, and reported delirium presence, duration, or severity with no language or region restrictions. PROSPERO ID: CRD42022367715. Two authors independently screened records and extracted data. Risk of bias was evaluated using Risk of Bias 2 or the Risk of Bias In Non-randomized Studies of Interventions. We pooled data using the Hartung-Knapp Sidik-Jonkmann random effects model. PRISMA was followed. Results From 8,054 citations, 90 studies (119,230 patients) published between 2001 and 2023 were included in the systematic review. 41 studies were included in the primary meta-analysis examining prevalent delirium: seven studies evaluated pain; 12 studies evaluated fentanyl; and five studies evaluated morphine. There was a trend to association between pain and delirium occurrence (OR 2.49, 95% CI 0.98–6.30), and a significant association between pain and incident delirium (OR 3.70, 95% CI 1.73–7.93). Fentanyl (OR 2.49, 95% CI 1.45–4.27) and morphine (OR 2.13, 95% CI 1.21–3.75) were associated with delirium occurrence. Risk of bias was critical for many studies. Conclusions We observed an association between pain and incident delirium among critically ill adults. Exposure to morphine or fentanyl (but no other pain medications) was associated with increased risk of delirium occurrence.
- 22 January 2025
- Published by Springer Nature in Intensive Care Medicine
- Vol. 51 (2) , 342-352
The association between pain, analgesia, and delirium among critically ill adults: a systematic review and meta-analysis
Purpose We performed a systematic review with meta-analysis examining the relationship between pain or pain medications and delirium occurence, duration, and severity. Methods We searched MEDLINE, EMBASE, CINAHL and the Cochrane Central Register of Controlled Trials from inception to May 15, 2023. We included randomised or observational studies among critically ill adults, that reported data on pain or exposure to analgesics, and reported delirium presence, duration, or severity with no language or region restrictions. PROSPERO ID: CRD42022367715. Two authors independently screened records and extracted data. Risk of bias was evaluated using Risk of Bias 2 or the Risk of Bias In Non-randomized Studies of Interventions. We pooled data using the Hartung-Knapp Sidik-Jonkmann random effects model. PRISMA was followed. Results From 8,054 citations, 90 studies (119,230 patients) published between 2001 and 2023 were included in the systematic review. 41 studies were included in the primary meta-analysis examining prevalent delirium: seven studies evaluated pain; 12 studies evaluated fentanyl; and five studies evaluated morphine. There was a trend to association between pain and delirium occurrence (OR 2.49, 95% CI 0.98–6.30), and a significant association between pain and incident delirium (OR 3.70, 95% CI 1.73–7.93). Fentanyl (OR 2.49, 95% CI 1.45–4.27) and morphine (OR 2.13, 95% CI 1.21–3.75) were associated with delirium occurrence. Risk of bias was critical for many studies. Conclusions We observed an association between pain and incident delirium among critically ill adults. Exposure to morphine or fentanyl (but no other pain medications) was associated with increased risk of delirium occurrence.
- Open Access
- 27 September 2024
- Published by Frontiers Media SA in Frontiers in Transplantation
- Vol. 3, 1458563
Variability in pediatric and neonatal organ offering, acceptance and utilization: a survey of Canadian pediatric transplant programs and organ donation organizations
Introduction: Solid organ transplantation in children is a lifesaving therapy, however, pediatric organ donation rates remain suboptimal.Methods: We conducted a cross-sectional survey of Canadian organ donation organizations (ODOs) and pediatric transplant programs (TPs), aiming to describe policies and practices for pediatric organ allocation, acceptance, and utilization in Canada.Results: Response rates were 82% and 83% respectively for ODOs and transplant programs comprising 7 kidney, 3 heart, 2 lung, 2 liver and 1 intestine programs. All 9 ODOs reported offering pediatric organs following death by neurological criteria (DNC), while 8 reported offering organs following death by circulatory criteria (DCC) for some organs. Variability was found across ODOs and TPs. There was little agreement on both absolute and organ-specific donor exclusion criteria between ODOs. There was further disagreement in organ specific acceptance criteria between ODOs and TPs and between TPs themselves. Notably, despite the development of pediatric donation after DCC guidelines, organs from DCC donors are excluded by many ODOs and TPs.Discussion: Further variability in pediatric specific training, policies, and allocation guidelines are also documented. Significant areas for improvement in standardization in organ acceptance, offering, and allocation in pediatric donation and transplantation across Canada were identified.
- 27 September 2024
- Published by Frontiers Media SA in Frontiers in Transplantation
- Vol. 3, 1458563
Open AccessVariability in pediatric and neonatal organ offering, acceptance and utilization: a survey of Canadian pediatric transplant programs and organ donation organizations
Introduction: Solid organ transplantation in children is a lifesaving therapy, however, pediatric organ donation rates remain suboptimal.Methods: We conducted a cross-sectional survey of Canadian organ donation organizations (ODOs) and pediatric transplant programs (TPs), aiming to describe policies and practices for pediatric organ allocation, acceptance, and utilization in Canada.Results: Response rates were 82% and 83% respectively for ODOs and transplant programs comprising 7 kidney, 3 heart, 2 lung, 2 liver and 1 intestine programs. All 9 ODOs reported offering pediatric organs following death by neurological criteria (DNC), while 8 reported offering organs following death by circulatory criteria (DCC) for some organs. Variability was found across ODOs and TPs. There was little agreement on both absolute and organ-specific donor exclusion criteria between ODOs. There was further disagreement in organ specific acceptance criteria between ODOs and TPs and between TPs themselves. Notably, despite the development of pediatric donation after DCC guidelines, organs from DCC donors are excluded by many ODOs and TPs.Discussion: Further variability in pediatric specific training, policies, and allocation guidelines are also documented. Significant areas for improvement in standardization in organ acceptance, offering, and allocation in pediatric donation and transplantation across Canada were identified.